Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
371 studies found for:    Open Studies | "Stomach Neoplasms"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Stomach Neoplasms" (371 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Recruiting Study Evaluating the Efficacy and Safety With CAR-T for Stomach Cancer
Condition: Stomach Neoplasms
Intervention: Biological: EPCAM-targeted CAR-T cells
2 Recruiting Irinotecan as 3rd Line Therapy in Gastric Cancer
Condition: Stomach Neoplasms
Intervention: Drug: Irinotecan
3 Recruiting Treatment Strategy for Stage IV Gastric Cancer With Positive Peritoneal Cytology as the Only Non-curable Factor
Condition: Stomach Neoplasm
Interventions: Procedure: standard gastrectomy with D2 lymphadenectomy;   Procedure: hyperthermic intraperitoneal chemotherapy;   Procedure: Extensive intraperitoneal lavage;   Other: Preoperative chemotherapy;   Other: Postoperative chemotherapy
4 Recruiting Study on Laparoscopic Spleen-Preserving No. 10 Lymph Node Dissection for Advanced Gastric Cancer
Condition: Stomach Neoplasms
Intervention: Procedure: Laparoscopic Spleen-Preserving No.10 Lymph Node Dissections
5 Not yet recruiting Serological Screening of Gastric Cancer in Wuxi Region
Condition: Stomach Neoplasms
Intervention: Device: serological examination and gastroscope
6 Not yet recruiting Endodrill vs. Conventional Biopsy. Evaluation of Diagnostic Capacity in Diffuse Gastric Cancer
Condition: Stomach Neoplasms
Interventions: Device: Boston Scientific Large Capacity with needle Biopsy;   Device: Endodrill 1A (BIBBInstruments, Lund, Sweden)
7 Recruiting Lifestyle Intervention for Prevention of Gastric Neoplasm
Condition: Stomach Neoplasms
Intervention: Behavioral: Active measures of lifestyle modification
8 Not yet recruiting ctDNA for Prediction of Relapse in Gastric Cancer
Condition: Stomach Neoplasms
Intervention: Other: ctDNA test
9 Recruiting Comparison of SEEOX and SOX Regimens in Stage ⅢB/ⅢC Gastric Cancer Patients
Conditions: Stomach Neoplasms;   Gastric Cancer
Interventions: Drug: oxaliplatin;   Drug: etoposide;   Drug: pharmorubicin;   Drug: S-1
10 Not yet recruiting Neoadjuvant Chemotherapy With SEEOX Regimen for Borrmann Type 4 Gastric Cancer
Conditions: Stomach Neoplasms;   Gastric Cancer
Interventions: Drug: oxaliplatin;   Drug: etoposide;   Drug: epirubicin;   Drug: S1
11 Recruiting Irreversible Electroporation(IRE) For Unresectable Stomach Neoplasms
Condition: Stomach Neoplasms
Interventions: Procedure: Irreversible electroporation (IRE);   Device: NanoKnife
12 Recruiting Phase 3 Study of Xelox Followed by Maintenance Capecitabine in the Advanced Gastric Cancer
Condition: Stomach Neoplasms
Intervention: Drug: Capecitabine
13 Recruiting Prophylactic or Preemptive Entecavir in Patients With Gastric Cancer Who Are Inactive Hepatitis B Carriers
Condition: Stomach Neoplasms
Intervention: Drug: Entecavir
14 Recruiting Impact of Adjuvant FOLFOX on Quality of Life and Sensory Neurotoxicity in Patients With Advanced Gastric Cancer
Condition: Stomach Neoplasms
Intervention: Other: Quality of life assessment
15 Recruiting Three Drugs in Advanced Gastric Cancer Neoadjuvant Chemotherapy for Stage Ⅲ Clinical Study
Condition: Gastric Cancer
Interventions: Drug: docetaxel,0xaliplatin,capecitabine;   Drug: oxaliplatin,capecitabine
16 Recruiting Early Onset and Familial Gastric Cancer Registry
Condition: Gastric Cancer
Intervention: Behavioral: questionnaires
17 Recruiting Circulating Exosomes As Potential Prognostic And Predictive Biomarkers In Advanced Gastric Cancer Patients ("EXO-PPP Study")
Condition: Gastric Cancer
Intervention:
18 Recruiting Chemotherapy Options for the First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancer
Condition: Gastric Cancer
Interventions: Drug: Capecitabine/cisplatin;   Drug: S-1/cisplatin;   Drug: Capecitabine/oxaliplatin;   Drug: 5-fluorouracil/oxaliplatin;   Drug: Capecitabine;   Drug: S-1;   Drug: 5-fluorouracil
19 Recruiting Dovitinib for Gastric Cancer With FGFR2 Amplification
Condition: Gastric Cancer
Intervention: Drug: Dovitinib
20 Recruiting NBI for Identifying Resection Margin Status in Gastric Cancer
Condition: Gastric Cancer
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.